L-NIL prevents renal microvascular hypoxia and increase of renal oxygen consumption after ischemia-reperfusion in rats

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 5, 2009, Pages

  Legrand, Matthieu ^a,b   Almac, Emre ^a   Mik, Egbert G ^c   Johannes, Tanja ^d   Kandil, Asli ^e   Bezemer, Rick ^a   Payen, Didier ^b   Ince, Can ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Acute kidney injury; Microcirculation; Nitric oxide

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; L N6 (1 IMINOETHYL)LYSINE HYDROCHLORIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEMODYNAMIC PARAMETERS; HYPOXIA; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; RAT; RENAL HYPOXIA; REPERFUSION INJURY; TISSUE OXYGENATION;

EID: 66049118299     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90371.2008     Document Type: Article

References (40)

1. Adler S, Huang H, Loke KE, Xu X, Tada H, Laumas A, Hintze TH. Endothelial nitric oxide synthase plays an essential role in regulation of renal oxygen consumption by NO. Am J Physiol Renal Physiol 280: F838-F843, 2001. (Pubitemid 32193508)
2. Ajayi AAL, Hercule HC, Pamugo J, Dixon D, Oyekan AO. Interactions of the renin-angiotensin system and alpha-1 adrenoceptors on renal hemodynamics in healthy and acute renal failure rats: the role of nitric oxide. Blood Press 10: 238-246, 2001. (Pubitemid 33149905)
3. Bagshaw SM. The long-term outcome after acute renal failure. Curr Opin Crit Care 12: 561-566, 2006.
4. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281: F887-F899, 2001. (Pubitemid 33123835)
5. 4a.Bateman RM, Sharpe MD, Goldmen D, Lidington D, Ellis CG. Inhibiting nitric oxide overproduction during hypotensive sepsis increases local oxygen consumption in rat skeletal muscle. Crit Care Med: 36: 359-360, 2008.
6. Boer R, Ulrich WR, Klein T, Mirau B, Haas S, Baur I. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol 58: 1026-1034, 2000.
7. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199-2210, 2003.
8. Brezis M, Heyman SN, Epstein FH. Determinants of intrarenal oxygenation. II. Hemodynamic effects. Am J Physiol Renal Fluid Electrolyte Physiol 267: F1063-F1068, 1994. (Pubitemid 124005388)
9. Brodsky SV, Yamamoto T, Tada T, Kim B, Chen J, Kajiya F, Goligorsky MS. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 282: F1140-F1149, 2002. (Pubitemid 34654480)
10. Brown GC. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 369: 136-139, 1995.
11. Chatterjee PK, Patel NS, Kvale EO, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Thiemermann C. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 61: 862-871, 2002. (Pubitemid 34175453)
12. Clementi E, Brown GC, Foxwell N, Moncada S. On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci USA 96: 1559-1562, 1999. (Pubitemid 29098490)
13. Cowley AW Jr, Mori T, Mattson D, Zou AP. Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regul Integr Comp Physiol 284: R1355-R1369, 2003. (Pubitemid 36621413)
14. Demirci C, Gargili A, Kandil A, Cetinkaya H, Uyaner I, Boynuegri B, Gumustas MK. Inhibition of inducible nitric oxide synthase in murine visceral larva migrans: effects on lung and liver damage. Chin J Physiol 49: 326-334, 2006.
15. Dunphy I, Vinogradov SA, Wilson DF. Oxyphor R2 and G2: phosphors for measuring oxygen by oxygen-dependent quenching of phosphorescence. Anal Biochem 310: 191-198, 2002. (Pubitemid 35388261)
16. Giulivi C, Kato K, Cooper CE. Nitric oxide regulation of mitochondrial oxygen consumption I: cellular physiology. Am J Physiol Cell Physiol 291: C1225-C1231, 2006.
17. Goligorsky MS, Brodsky SV, Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 61: 855-861, 2002.
18. Goligorsky MS, Brodsky SV, Noiri E. NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology. Semin Nephrol 24: 316-323, 2004.
19. Ichihara A, Hayashi M, Navar LG, Saruta T. Inducible nitric oxide synthase attenuates endothelium-dependent renal microvascular vasodilation. J Am Soc Nephrol 11: 1807-1812, 2000.
20. Johannes T, Mik EG, Klingel K, Dieterich HJ, Unertl KE, Ince C. Low-dose dexamethasone supplemented fluid resuscitation reverses endotoxin- induced acute renal failure and prevents cortical microvascular hypoxia. Shock 2008 Sep 29. [Epub ahead of print]
21. 20a.Jones SP, Greer JJ, Kakkar AK, Ware PD, Turange RH, Hicks M, van Haperen R, de Crom R, Kawashima S, Yokoyama M, Lefer DJ. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 286: H276-H282, 2004.
22. Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H. Expression of inducible-NOS in human glomerulonephritis: the possible source is infiltrating monocytes/macrophages. Kidney Int 50: 392-399, 1996. (Pubitemid 26274364)
23. Kleinert H, Pautz A, Linker K, Schwarz PM. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 500: 255-266, 2004. (Pubitemid 39304013)
24. Kone BC, Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol Renal Physiol 272: F561-F578, 1997. (Pubitemid 27382204)
25. Korkeila M, Ruokonen E, Takala J. Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med 26: 1824-1831, 2000. (Pubitemid 32010000)
26. Laycock SK, Vogel T, Forfia PR, Tuzman J, Xu X, Ochoa M, Thompson CI, Nasjletti A, Hintze TH. Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 82: 1263-1271, 1998. (Pubitemid 28294745)
27. Lefer DJ, Jones SP, Girod WG, Baines A, Grisham MB, Cockrell AS, Huang PL, Scalia R. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol Heart Circ Physiol 276: H1943-H1950, 1999. (Pubitemid 29323478)
28. Legrand M, Ince C, Mik E, Johannes T, Payen D. Renal hypoxia and dysoxia following reperfusion of the ischemic kidney. Mol Med 14: 502-516, 2008.
29. Lounsbury KM, Hu Q, Ziegelstein RC. Calcium signaling and oxidant stress in the vasculature. Free Radic Biol Med 28: 1362-1369, 2000. (Pubitemid 30621480)
30. Molitoris BA, Sandoval R, Sutton TA. Endothelial injury and dysfunction in ischemic acute renal failure. Crit Care Med 30: S235-240, 2002. (Pubitemid 34507997)
31. Moore WM, Webber RK, Jerome GM, Tjoeng FS, Misko TP, Currie MG. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem 37: 3886-3888, 1994.
32. Rusai K, Fekete A, Szebeni B, Vannay A, Bokodi G, Muller V, Viklicky O, Bloudickova S, Rajnoch J, Heemann U, Reusz G, Szabo A, Tulassay T, Szabo AJ. Effect of inhibition of neuronal nitric oxide synthase and L-arginine supplementation on renal ischaemia-reperfusion injury and the renal nitric oxide system. Clin Exp Pharmacol Physiol 35: 1183-1189, 2008.
33. Schwartz D, Mendonca M, Schwartz I, Xia Y, Satriano J, Wilson CB, Blantz RC. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100: 439-448, 1997. (Pubitemid 27349092)
34. Senturk LM, Seli E, Gutierrez LS, Mor G, Zeyneloglu HB, Arici A. Monocyte chemotactic protein-1 expression in human corpus luteum. Mol Hum Reprod 5: 697-702, 1999. (Pubitemid 29366864)
35. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, Molitoris BA. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 285: F191-F198, 2003.
36. Tyml K, Li F, Wilson JX. Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism. Crit Care Med 36: 2355-2362, 2008.
37. Vinogradov SA, Fernandez-Seara MA, Dupan BW, Wilson DF. A method for measuring oxygen distributions in tissue using frequency domain phosphorometry. Comp Biochem Physiol A Mol Integr Physiol 132: 147-152, 2002.
38. Welch WJ, Baumgartl H, Lubbers D, Wilcox CS. Nephron PO2 and renal oxygen usage in the hypertensive rat kidney. Kidney Int 59: 230-237, 2001. (Pubitemid 32055230)
39. Ysebaert DK, De Greef KE, Vercauteren SR, Ghielli M, Verpooten GA, Eyskens EJ, De Broe ME. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 15: 1562-1574, 2000.
40. Zhang L, Looney CG, Qi WN, Chen LE, Seaber AV, Stamler JS, Urbaniak JR. Reperfusion injury is reduced in skeletal muscle by inhibition of inducible nitric oxide synthase. J Appl Physiol 94: 1473-1478, 2003. (Pubitemid 36348825)